Pfizer to buy cancer drug developer Trillium in $3.1b deal

Trillium’s two lead molecules, TTI-622 and TTI-621, block signalling proteins involved in blood cancers, and are both in human trials across several types of disease.

from Sydney Morning Herald - Latest News
Read More

No comments:

Post a Comment

Thank You for sharing your views. I hope you like the arts posted.

Alzheimer's / Dementia News From Medical News Today

Highlights Today !

Salma Hayek portrait

  Salma Hayek Hi all, This Salma Hayek portrait is made on an A4 size brustro paper with the help of charcoal and graphite pencils. You can ...

Most viewed post